Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Genfit (GNFT) Stock Price & Analysis

GNFT Stock Chart & Stats

€10.86-€0.54(-4.74%)
At close: 5:30 PM GMT+1
EUR 7.5EUR 10EUR 12.53 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
EUR 10.74 - EUR 11.72
52-Week Range
EUR 3.40 - EUR 15.48
Previous Close
EUR 11.40
Volume
267.52K
Average Volume (3M)
451.11K
Market Cap
EUR 541.90M
Enterprise Value
EUR 595.85M
Total Cash (Recent Filing)
EUR 113.82M
Total Debt (Recent Filing)
EUR 179.28M
Price to Earnings (P/E)
―
Beta
1.31
Next Earnings
Apr 08, 2027 (Est.)
EPS Estimate
-0.37
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Revenue Growth

The sharp 2025 revenue rebound indicates renewed commercial or partnering activity across Genfit’s business and provides a stronger base for future scale. If this growth continues, it could improve operating leverage and support investment in the company’s therapeutic and diagnostic pipeline.

Focused Therapeutic And Diagnostic Platform

Genfit’s focused positioning in metabolic and liver diseases gives its development efforts a coherent strategic direction rather than a broad, unfocused pipeline. Combining treatments with diagnostics may support patient identification and stratification across related disease programs.

Demonstrated Profitability Potential

Positive EBIT, EBITDA, and net income in 2024 demonstrate that Genfit has previously converted its activities into accounting profits. Although 2025 reversed that outcome, the earlier result provides evidence of potential earnings capacity if revenue growth and cost control become more consistent.

Bears Say

Balance-Sheet Stress

The shift to negative shareholders’ equity materially weakens Genfit’s financial resilience and reduces flexibility to absorb continued losses. Higher debt adds funding pressure, while the combination of leverage and negative equity may constrain investment in clinical development and increase reliance on external capital.

Renewed Cash Burn

Negative operating and free cash flow indicate that the business was not self-funding in 2025 and had to absorb renewed cash consumption. The broader history of several negative-cash-flow years suggests this is a recurring sustainability issue rather than an isolated period of investment.

Unstable Profitability

The disconnect between strong revenue growth and a return to large operating and net losses shows that top-line expansion has not yet translated into durable profitability. Earnings have also varied sharply across years, reducing confidence in predictable margins and long-term earnings conversion.

Genfit News

GNFT FAQ

What was Genfit’s price range in the past 12 months?
Genfit lowest stock price was €3.40 and its highest was €15.48 in the past 12 months.
What is Genfit’s market cap?
Genfit’s market cap is €541.90M.
When is Genfit’s upcoming earnings report date?
Genfit’s next earnings report is estimated for Apr 08, 2027 (not yet confirmed), which is in 158 days.
How were Genfit’s earnings last quarter?
Genfit released its earnings results on Sep 28, 2026. The company reported -€0.2 earnings per share for the quarter, missing the consensus estimate of -€0.16 by -€0.04.
Is Genfit overvalued?
According to Wall Street analysts Genfit’s price is currently Undervalued.
Does Genfit pay dividends?
Genfit does not currently pay dividends.
What is Genfit’s EPS estimate?
Genfit’s EPS estimate is -0.37.
How many shares outstanding does Genfit have?
Genfit has 50,099,620 shares outstanding.
What happened to Genfit’s price movement after its last earnings report?
Genfit reported an EPS of -€0.2 in its last earnings report, missing expectations of -€0.16. Following the earnings report the stock price went up 10.314%.
Which hedge fund is a major shareholder of Genfit?
Currently, no hedge funds are holding shares in FR:GNFT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology